Submitted by Anonymous (not verified) on 2 March 2026 - 9:52
Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised